Ascletis Pharma, Inc.'s total assets for Q4 2025 were ¥2.07B, an increase of 3.53% from the previous quarter. HK:1672 total liabilities were ¥129.93M for the fiscal quarter, a 0.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.